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Fourminimal (119 - 145 residue) active site fragments ofEsch-
erichia coli Class II histidyl-tRNA synthetase were constructed,
expressed as maltose-binding protein fusions, and assayed for
histidine activation as fusion proteins and after TEV cleavage,
using the 32PPi exchange assay. All contain conserved Motifs 1
and 2. Two contain an N-terminal extension of Motif 1 and two
containMotif 3. Five experimental results argue strongly for the
authenticity of the observed catalytic activities: (i) active site
titration experiments showing high (0.1–0.55) fractions of
active molecules, (ii) release of cryptic activity by TEV cleavage
of the fusion proteins, (iii) reduced activity associated with an
active site mutation, (iv) quantitative attribution of increased
catalytic activity to the intrinsic effects of Motif 3, the N-termi-
nal extension and their synergistic effect, and (v) significantly
altered Km values for both ATP and histidine substrates. It is
therefore plausible that neither the insertion domain nor Motif
3 were essential for catalytic activity in the earliest Class II ami-
noacyl-tRNA synthetases. The mean rate enhancement of all
four cleaved constructs is 109 times that of the estimated
uncatalyzed rate. As observed for the tryptophanyl-tRNA syn-
thetase (TrpRS) Urzyme, these fragments bind ATP tightly but
have reduced affinity for cognate amino acids. These fragments
thus likely represent Urzymes (Ur  primitive, original, earliest 
enzyme) comparable in size and catalytic activity and coded by
sequences proposed to be antisense to that coding the previ-
ously described Class I TrpRS Urzyme. Their catalytic activities
provide metrics for experimental recapitulation of very early
evolutionary events.
The complexity of contemporary enzymes makes it almost
certain that ancestral forms were simpler polypeptides. These
primordial ancestors have, however, long been extinct. It has
been impossible to recapitulate, even approximately, how they
functioned without modules that enhance the fitness of con-
temporary enzymes.
Experimental study of ancestral enzymes began with the
inference frommultiple sequence alignments of the amino acid
sequence for a ribonuclease belonging to an ancestral ruminant
(1). Construction of this ancestral gene allowed expression and
experimental characterization of the corresponding protein.
More recently, this approach, known as “ancestral gene resur-
rection,” has led to several novel insights into how point muta-
tions in ligand-binding domains of nuclear hormone receptors
resulted in irreversible adaptation to entirely new ligands
(2–4).
Despite such successes, we still know very little about how
the earliest protein catalysts evolved to the point where ances-
tral gene resurrection from extant multiple sequence align-
ments (5–8) becomes possible. There are two requisites for
addressing this problem. First, model peptides expected to
mimic primordial enzymes must be constructed based on
observations other than sequence phylogenies. Second, models
must havemeasurable activity, to provide an experimentalmet-
ric (9) for assessing recapitulation of putative evolutionary
events.
We chose to study the aminoacyl-tRNA synthetases (aaRS)2
for a variety of important reasons; (i) these enzymes accelerate
amino acid activation which, in the absence of catalysts, is the
slowest step along the pathway of protein synthesis3; perhaps
107 times slower than peptide bond formation uncatalyzed (11).
For this reason aaRSwere therefore likely among the first prim-
itive polypeptide catalysts to evolve; (ii) the twenty canonical
aaRS divide evenly into two quite distinct superfamilies whose
structures are apparently unrelated; (iii) there is precedent for
the catalytic activity of fragments derived frombothClass I (12)
and Class II (13, 14) aminoacyl-tRNA synthetases. Histidyl
tRNA synthetase (HisRS) presents a particularly good system
because the steady-state kinetic properties of a 320-residue
N-terminal fragment containing the intact catalytic domain
have been extensively characterized (14).
We used three-dimensional structural superposition, rather
than multiple sequence alignments to identify a peptide scaf-
fold that positions the active site residues for a bacterial Class I
tryptophanyl-tRNA synthetase, TrpRS. That 130-residue pro-
tein accelerates amino acid activation by 109, relative to the
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estimated uncatalyzed rate of 8.3 109/mol/s (15).Moreover,
steady-state kinetic parameters showed that it bindsATP about
as well as the full-length, native enzyme but has 2000-fold
weaker affinity for tryptophan (16). Because it was catalytically
active and appeared to approach a limiting size necessary to
position the conserved catalytic residues, we called that con-
struct anUrzyme.On the basis of thatwork,wehoped to be able
to document similar catalytic activity for Class II Urzymes.
We report here the construction and catalytic activity of a
series of constructs created from the contemporary Class II
histidyl-tRNA synthetase, HisRS. Class II aaRS are defined by
three highly conserved signature peptides, referred to asMotifs
1–3. Motif 2 comprises the ATP binding site and provides a
partial platform for amino acid binding.
The four constructs described here were extracted from the
gene for contemporary Escherichia coli HisRS. No use was
made of protein design to compensate for the deletion of 300
amino acids. Despite the absence of a systematic approach to
redesign a stable fold, active site titration experiments demon-
strate that significant fractions of the molecules contribute to
the observed activities.We then show that the activity is cryptic
in maltose-binding protein fusions, that it is significantly
enhanced upon TEV cleavage and that for both fusion proteins
and cleaved products, a six-residue N-terminal extension pre-
ceding theMotif 1 helix and a 20-residue C-terminal extension
containing Motif 3 both contribute consistently to the overall
rate acceleration. An active site mutation alters the observed
activity of one construct. Finally,Michaelis parameters for ATP
and histidine for one construct differ markedly from those of
native HisRS.
Additional motivation for these studies comes from our
desire to test the unusual hypothesis of Rodin and Ohno (17).
According to their hypothesis, the two classes of aaRS
descended from a single ancestral gene, one strand of which
coded for an ancestral Class I, whereas the other strand coded
for the ancestral Class II synthetase. Catalytic activity of a Class
II construct composed of the amino acids hypothesized to lie
opposite the ancestral Class I enzyme would provide substan-
tial, complementary new evidence for sense/antisense ancestry.
Together with our previous work on the TrpRS Urzyme,
these results document that comparable cognate amino acid
activation activities arise from both Class I and Class II
Urzymes of similar length (120–130 residues) in which the
conserved signature peptides of the two classes can be arranged
approximately antiparallel and opposite one another in keeping
with the Rodin-Ohno hypothesis. Moreover, their steady-state
kinetic parameters appear appropriate to activate, relatively non-
specifically, the two types of amino acids required for binary
encoding of the earliest ancestral globular proteins (18–20).
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmid Construction—Restriction
enzymes and other molecular biology reagents were obtained
from New England Biolabs. Genes for HisRS-1 (residues
16–134) and HisRS-2 (residues 10–134), were amplified by
PCR from Ncat_HisRS (PQE-30; (14)). Genes for HisRS-3/4
were extended from HisRS-1/2 sequentially by PCR until they
contained coding sequences for residues 301–320, which com-
prise Motif 3. This procedure formed a peptide bond between
residues Gly134 and Pro301 in HisRS 3/4. An EcoRI restriction
site, TEV protease cleavage site, and FLAG tagwere included in
the primers for the 5 end, and a HindIII restriction site was
added at the 3 end of the fragments. Following the double
digestion with EcoRI and HindIII, the HisRS-1–4 constructs
were cloned to E. coli expression plasmid vector pMAL-c2X
(New England Biolabs). All constructs were confirmed by DNA
sequencing. Bacterial strain BL21(DE3)pLysS (Novagen) was
used for the expression of all HisRS constructs.
Protein Expression and Purification—The MBP-HisRS
fusion proteins were expressed and purified using amylose
resin according to the manufacturer’s instructions (New Eng-
land Biolabs). Overnight cultures of E. coli transformed with
recombinant plasmid (pMal-c2X/HisRS1–4 Urgenes) were
diluted in fresh LBmedium containing 100 g/ml of ampicillin
toA600  0.5. Then, IPTGwas added to a final concentration of
0.3 mM to the culture broth. After 3 h of induction, the cells
were harvested by centrifugation at 12,000  g at 4 °C for 20
min. Cells were resuspended in 1/10 volume of chilled column
buffer (200 mM NaCl and 1 mM EDTA in 20 mM Tris-HCl
buffer, pH 7.4) and disrupted by sonication on ice and centri-
fuged at 12,000  g at 4 °C for 30 min. The crude extract was
incubated with amylose resin overnight at 4 °C with shaking,
and then poured into a Kontes Flex-Column. The column was
washedwith 12 volumes of columnbuffer. Fusion proteinswere
eluted with the same buffer containing 10 mMmaltose, and the
eluted fractions were pooled.
TEV Protease Cleavage and Separation of HisRS Constructs—
The purified MBP-HisRS fusion proteins were concentrated to
at least 1 mg/ml in an Amicon Centricon (Millipore Corp. Bed-
ford, MA). To cleave the fusion proteins, TEV protease was
added to the MBP-HisRS fusion proteins (1:30) and incubated
at 4 °C for 24 h. The cleavage mixtures were stored at 4 °C for
the activity assay and further purification. HisRS constructs
could be purified from cleavage mixtures using anti-FLAGM2
affinity gel according to the manufacturer’s protocols (Sigma).
Active Site Titration—The concentrations of active sites,
compared with the total concentrations of HisRS fusion pro-
teins were determined using the active site titration procedure
as described (21) using 10mM -32P-labeled ATP in excess over
the total estimated enzyme concentration. Reactions were
quenched with SDS at 14 time intervals between 1 and 50 min,
and aliquots were examined by thin-layer chromatography on
polyethyleneimine cellulose. Plateswere scanned after develop-
ment using a Typhoon phosphoimaging device. Amounts of
labeled ATP and PPi were estimated from densitometry and
fitted to relation (Equation 1) using JMP (22).
ATP  A  exp	kchem  t
  kcat  t  C (Eq. 1)
The active fraction, n, is obtained from the fitted parameters
(23) as in Equation 2.




Enzymatic Assays—Samples were assayed in 96-well format,
using the traditional [32P]pyrophosphate exchange in the pres-
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ence of the cognate histidine substrate, as described (24, 25). A
3-fold reduction of background 32P counts was achieved by col-
lecting the charcoal containing labeledATP on disposable filter
plates (Whatman Microplate unifilter devices), washing, and
eluting the bound ATP with 50 l of pyridine at 37 °C (15). A
unit of activity is 1M[32P]ATP formedperminute.Controlswith
calibrated amounts of labeled ATP were performed to determine
the elution efficiency, which was used to correct the experimental
results. Four replicates were performed for each measurement.
Michaelis-Menten experiments were carried out for one of the
four constructs (HisRS3) by varying the ATP and histidine con-
centrations.Concentration-dependent rateswere fittedusing JMP
(22).
RESULTS
Structural Design Considerations—Rodin and Ohno (17)
suggested two serious problems associated with their attempt
to align theClass I PxxxHIGHandKMSKS sequences sense and
antisense with those of Class II Motifs 2 and 1 (Fig. 1A). First,
the long and variable CP1 (connecting peptide) insertion pre-
cludes simultaneous alignment of both Class I signatures onto
Motifs 2 and 1,which are always separated by100 amino acids
in Class II aaRS (15). Furthermore, the active site in full-length
Class II aaRS includes what appear to be class-defining contri-
butions from Motif 3, which is separated from the C-terminal
end of theMotif 2 loop by a long and variable insertion domain
(26) that is 170 amino acids long in E. coli HisRS, and hence
has no N-terminal (antisense) counterpart in many Class I
aaRS. Thus, to complement our previous demonstration that
Class I catalytic activity does not require the presence of the
CP1 insertion, we wished to show here that Motif 3 and the
insertion domain also can eliminated without abolishing cata-
lytic activity from comparable Class II constructs.
Four HisRS polypeptides derived from the HisRS Ncat
domain were produced by PCR-based subcloning of the appro-
priate fragments of the E. coli hisS gene into an expression vec-
tor. The catalytic apparatus in Class II aaRS is often
described in terms of an antiparallel, seven-stranded -sheet
with flanking helices (27). Our effort here is motivated by the
desire to identify much smaller segments of the contempo-
rary enzyme that retain measureable catalytic activity for
amino acid activation. For this purpose, we identified an
active site built around Motif 2, which forms the ATP-bind-
FIGURE 1. Motivation and construction of HisRS Urzymes. A, the Rodin-Ohno sense/antisense ancestry hypothesis. Class I and II aaRS proteins are aligned in
opposite directions with Class II Motifs 2 and 1 opposite Class I PxxxxHIGH and KMSKS signature peptides. Coding sequences for these four peptides have
statistically significant reverse complement homology ((17), filled rectangles). Ancestry of the boldface lines connecting them is incompatible with the Class I
CP1 insertion (dashed line). As many Class I aaRS begin within 10 residues of the PxxxxHIGH signature, sense/antisense ancestry is also incompatible with the
presence of the insertion domain (ID, dashed line) in primordial Class II aaRS. B, schematic maps of HisRS1– 4. Motifs 1–3 are conserved peptides that define Class
II aaRS (39). The N-terminal catalytic domain was described previously (14). The four Urzymes, HisRS1– 4, were constructed in this work. C, three-dimensional
structures derived from the 2EL9 crystal structure. Colors match those in B.
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ing site, and the -strand and -helix immediately preceding
the Motif 2 loop, which comprise much of the amino acid
binding site.
Residues Gly134 and Pro301 are ideally positioned to form a
-turn (Fig. 2A) between Motifs 2 and 3. This enabled us to
connect the two Motifs directly, without applying the Loop
algorithm in Rosetta as we did when removing the internal CP1
peptide in the TrpRS Urzyme (16, 28). None of the conserved
residues definingMotif 1 occur before residueGly37, which is at
the C terminus of what has become known as the “Motif 1
-helix”.We nevertheless elected to include the entire length of
this helix in all constructs. Moreover, an N-terminal extension
to this helix forms a number of contacts with the back of the
Motif 2 loop (Fig. 1C). We reasoned that this connectionmight
afford a detectable functional advantage and thus included var-
iation of this structural feature in the experimental design. The
resulting constructs, summarized in Fig. 1, B and C, are as fol-
lows: HisRS1, residues 16–134; HisRS2, residues 10–134;
HisRS3, residues 16–134 and 301–320; and HisRS4, residues
10–134 and 301–320.
Purification of HisRS-3 fromTEVCleavageMixture Does Not
Significantly Alter Its Specific Activity—Purification of the four
constructs is illustrated in Fig. 3, together with the results of TEV
cleavage. TheMBP andHisRS fragments are of sufficiently differ-
ent sizes that we expected to be able to separate themby gel filtra-
tion.We attempted this separation on a ShodexKW-803 column.
However, the broad elution profile and the absence of a clear sep-
aration (data not shown) implied that the cleaved mixture was
aggregated. This aggregation also precluded any clear answer as to
the quaternary structure of the active Urzyme.
However, we isolated sufficient HisRS-3 fusion protein to
separate theHisRS construct frombothMBPand from theTEV
enzyme itself using anti-FLAG antibody. The HisRS-3-specific
activities before and after this purification were 1.7 and 1.3
units/mg. Given the similarity of these two values and the high
cost of purification, which entails substantial loss of material,
we characterized the remaining HisRS constructs in their
respective TEV cleavage mixtures.
Active Site Titration of HisRS MBP Fusion Proteins Confirms
That Significant Fractions of Total Number of Molecules Con-
tribute to Observed Catalytic Activities—We previously used
active site titration (21, 23) to show that the observed activity of
the TrpRS Urzyme derived from significant fractions of the
total Urzyme concentration (16). As with the TrpRS Urzyme,
the HisRS1–4 MBP fusion proteins are substantially less
active than are their TEV cleavage products. Furthermore,
despite their increased activity, the cleaved products of the
HisRS fusion proteins could not be concentrated in sufficient
quantity after TEV cleavage to increase the signal to noise in the
active site titration assays.We therefore titrated only the fusion
proteins themselves. Although there is variation between dif-
ferent preparations, the titration experiments show convinc-
ingly that substantial bursts occur (Fig. 4). Thus, as with the
TrpRS Urzyme, HisRS 1–4 all retain the histidyl-adenylate
intermediate, and turnover is limited, either by product release
or by the slow decomposition of the enzyme-bound adenylate.
Catalytic Activity Varies Consistently with Each of Three
Design Variables—The experimental design comprises a three-
factor, two-level factorial plan testing the effect on the activity
of three structural elements: TEV cleavage of the fusion pro-
tein, the presence of Motif 3, and the presence of the N-termi-
nal extension to the Motif 1 helix. The fusion purified proteins
(Fig. 3) were thus cleaved with TEV protease, and both the
cleaved and uncleaved preparations were tested for histidine
activation activity using the 32PPi exchange assay (29) as mod-
ified previously to enhance sensitivity (15).
Significant evidence that activities presented here represent
authentic catalysis by the HisRS constructs and do not arise
from contaminating full-length enzyme derives from the sys-
FIGURE 2. Rationale for the factorial construction design. A, the C-terminal (C) -strand of Motif 2 (blue) and N-terminal (N) -strand of Motif 3 (yellow) can
be connected by a -turn between residues Gly134 and Pro301. B, the N-terminal Motif 1 extension (red) makes extensive interactions with the back side of the
active site. C, Motif 3 (yellow) provides additional connections to the Motif 1 helix.
FIGURE 3. Purified HisRS1– 4 constructs. Lanes are labeled across the top in
pairs of fusion protein constructs and their TEV cleavage products. Extra
bands present in the cleavage products arise from TEV protease preparation.
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tematic variation of activity with the precise characteristics of
the different constructs. Neither MBP nor TEV protease by
itself has histidine activation activity. Specific activities of the
HisRS1–4 constructs, corrected for the fraction of active sites
in the respective fusion proteins, are compared in Fig. 5. There
are significant differences between the average activities of the
three groups of four experiments according to the factorial
design: four fusion proteins versus four cleaved products (Fig.
5A); four with versus four without Motif 3 (Fig. 5B), and four
with versus four without the N-terminal extension (Fig. 5C).
To assess the significance of these differences quantitatively,
we converted the specific activities to G values and fitted val-
FIGURE 4. Active site titration of the HisRS1– 4 MBP (A–D, respectively) fusion proteins. All fusion proteins display pre-steady-state bursts with significant
amplitudes (lower left corner). The y axis ([ATP]_n, rel) is the fraction of the initial value recorded in the absence of catalyst corrected for dilution.
FIGURE 5. Specific activities of the four HisRS constructs. HisRS-1, Motifs 1 and 2 only; HisRS-2, core  N-terminal (N-term) extension only; HisRS-3, core 
Motif 3 only; HisRS-4, core  N-terminal extension  Motif 3). Specific activities, corrected for the active fractions of the respective fusion proteins (Fig. 4), have
been converted to relative free energies by G  0.597  ln(Sp_Act). Error bars denote the S.D. for triplicate or quadruplicate measurements of each activity.
The three factorial variables TEV cleavage, the N-terminal extension (HisRS-2 and -4) and the presence of Motif 3 (HisRS-3 and -4), all have clearly significant
effects. However, the experimental signal-to-noise is comparable for the fusion proteins and their cleaved products. In all panels, the observed activities are
shaded according to the comparisons made in fitting the regression model (see Equation 3). Far left panel, activities of the fusion proteins (light gray bars) are
suppressed, relative to activities released on TEV cleavage (dark gray bars). Middle panel, activities of all four constructs containing Motif 3 (dark gray bars) are
elevated, relative to those that lack Motif 3 (light gray bars). Far right panel, activities of the four constructs containing the N-terminal extension are elevated
(dark gray bars), relative to those that lack it. A quantitative assessment is given in Table 2.
TABLE 1
Factorial design matrix for HisRS1– 4 Urzyme constructs
Variant TEV N terminus M3 Rate G‡
s1 kcal/mol
HisRS-1 0 0 0 0.018 2.404
HisRS-1TEV 1 0 0 1.070 0.040
HisRS-2 0 1 0 0.017 2.430
HisRS-2TEV 1 1 0 0.879 0.077
HisRS-3 0 0 1 0.015 2.501
HisRS-3TEV 1 0 1 1.067 0.038
HisRS-4 0 1 1 0.297 0.725
HisRS-4 0 1 1 0.283 0.753
HisRS-4 0 1 1 0.311 0.697
HisRS-4TEV 1 1 1 8.351 1.267
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ues for each of the eight constructs, Gi (Table 1), to a linear
multiple regression model, involving four effects (Equation 3)
to obtain least-squares estimates for the catalytic contributions,
	G
 i  		G

  	G
Tev  TEV  	G
Nterm
 N-term  	G
M3  M3  	G
int)Nterm  M3  N-term
 M3 (Eq. 3)
where (G)Tev, (G)Nterm,M3 and (Gint)NtermM3 are
coefficients estimated by fitting. TEV, N-term, and M3 are
matrix elements from the corresponding columns in Table 1.
The coefficients represent the free energy contribution in kcal/
mol to transition state stabilization from TEV cleavage, the
N-terminal extension, Motif 3, and the synergy between the
N-terminal extension and TEV cleavage, respectively.
The units of specific activity, mol/s/mol protein, are those of
kcat. Values reported here, however, are lower bounds for kcat, as
we have not titrated the fraction of active sites for the cleaved
HisRS constructs. The Student’s t test probabilities indicate the
statistical significance of the coefficients and hence of the quan-
titative catalytic contributions of each of the four predictors.
These values are summarized, together with analysis of vari-
ance statistics, in Table 2. Consistent activity differences
between constructs with respect to each of the three design
variables would likely not be observed unless the HisRS con-
structs were the authentic source of the observed catalytic
activity.
Negative coefficients imply that the presence of the factor
reduces G‡, thus accelerating the rate of histidine activation.
TEV cleavage, the N-terminal extension, and Motif 3 each
accelerate the rate, with effects of different magnitude. TEV
cleavage lowers G‡ by 2.31 kcal/mol, or about three times
the extent afforded byMotif 3 and by the N-terminal extension
(0.8 kcal/mol).
The effect ofMotif 3 differs, depending onwhether or not the
construct containing it also has the N-terminal extension. This
effect is reflected in the sign of the interaction term (N-term
extension  TEV)  1.63 kcal/mol. It changes the G‡ by
only 0.83 kcal/mol in HisRS-3, which has only M3, but by
1.46 kcal/mol (0.83  0.19  1.63) kcal/mol in HisRS-4,
which has both.4 Thus, the contribution of both theN-terminal
extension orMotif 3 are enhanced if the other is present, due to
their synergistic interaction term.
Active Site Mutation R113A in HisRS-4 Reduces Activity
4-Fold—Arginine 113 is a strictly conserved basic residue in
theMotif 2 catalytic sequence. Density functional theory calcu-
lations suggest that it is critical to transition-state stabilization
of acyl transfer by HisRS transition state stabilization (30). We
therefore constructed the R113A mutant in HisRS-4, the most
active of the four constructs. Replicated assays of the WT and
R113A HisRS-4 MBP fusion proteins (Table 3) show that the
mutation reduces activity 4-fold, by an amount that is 9.8 times
the estimated S.D. of the measurements. This experiment pro-
vides orthogonal evidence that the observed activity resides in
the HisRS-4 construct and not another source of adventitious
contamination. We return in the discussion to the unexpect-
edly small magnitude of this mutational effect.
HisRS-3 Binds ATP Far More Tightly and Histidine Less
Strongly Than Native, Full-length HisRS or Its Intact Catalytic
Domain—Complementary evidence that the HisRS1–4 con-
structs are responsible for observed activities comes from the
fact that Michaelis-Menten Km values of HisRS-3 for ATP and
histidine are distinctly different from those of the full-length
enzyme or the Ncat catalytic domain (14). The activities of
HisRS-1–4 are roughly comparable, and the constructs are dif-
ficult to purify in large amounts. The HisRS-3 preparation pro-
vided a surplus of fusion protein, which we used to determine
Michaelis-Menten kinetic parameters for 32PPi exchange
(Fig. 6).
The histidine-dependentMichaelis-Menten experiment also
demonstrates that there is no activity in the absence of histi-
dine. As the exchange condition affords thermodynamic disso-
ciation parameters (31, 32), these experiments provide mea-
sures of the affinity of the HisRS-3 Uryzme for both substrates.
As is true for the TrpRS Urzyme (16), and in contrast to either
full-length enzyme, the HisRS-3 binds ATP (Km  15 M) an
order of magnitude more tightly than it does histidine (Km 
119 M). HisRS-3 binds both substrates an order of magnitude
more tightly in the ground state complexes than corresponding
substrates bind to theTrpRSUrzyme. It is worth noting that the
high ATP affinity implies that the HisRS constructs probably
use less of the binding energy resulting from interaction with
ATP to lower the transition state free energy than is observed
for the full-lengthHisRS.Moreover, the higherKm for histidine
is consistent with the fact that all constructs aremissing impor-
tant contact residues, e.g. the HisA loop, residues 257–264 in
the insertion domain (33).
DISCUSSION
Reconstruction of extinct enzymes from beyond the era that
is supported by awell defined sequence phylogeny is necessarily
controversial. It is thus worth summarizing at the outset the
4 The factor of 0.19 arises because JMP calculates the interaction term in
terms of (N-terminal  0.555)  (M3  0.555) because the absence and
presence of the two variables are coded by 0 and 1 in Table 1 and 0.44 
0.44  0.19.
TABLE 2
Regression modeling of HisRS Urzyme activities
Analysis of variance statistics were as follows:N(obs)  9; R2  0.993; F  22.1, and
p  F, 0.0002.
Term Estimate S.E. t Ratio p > t
Intercept 2.84 0.115 24.58  0.0001
TEV 2.31 0.110 20.92  0.0001
N-terminal extension 0.83 0.110 7.57 0.0016
M3 0.85 0.110 7.78 0.0015
N-terminal extension  M3 1.63 0.220 7.38 0.0018
TABLE 3
Specific Activities of HisRS4 R113A versus wild type HisRS 4_MBP
fusion proteins




HisRS-4, WT 1.38 0.09
HisRS4_R113A 0.33 0.06
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logic underlying our proposal that these fragmentary catalysts
are legitimate models for ancestral aminoacyl tRNA syntheta-
ses, that is that they do indeed do deserve to be called
“Urzymes.” There is widespread consensus that structural con-
servation is evidence for common ancestry. This phylogenetic
argument holds that themost highly conserved structures, both
sequences and three-dimensional structures, within contem-
porary enzyme families are most ancient. To this strong prior
prejudice that the most widely shared, invariant structures are
indeed the most ancestral, we have added essential experimen-
tal confirmation; these conserved fragments exhibit 9 of the
14 orders of magnitude in rate acceleration, i.e. they afford
65% of the transition state stabilization associated with the
contemporary enzymes.
Substrate-binding affinities reinforce the conclusion that the
TrpRS and HisRS Urzymes are plausible models for the early
Class I and Class II aaRS. Both Urzymes bind ATPmore tightly
than amino acid, consistent with the expectation that the pri-
mordial function of ancestral aaRS probably was to mobilize
ATP for chemical group activation. The posterior probability
that these Urzymes are legitimate models for ancestral aaRS is
therefore substantially strengthened by demonstrating such
significant catalytic activity and relative substrate specificites
(16). Viewed another way, we have shown experimentally that
significant catalytic activities and appropriate specificities are
associated with the most highly conserved, and hence arguably
most ancient portions of class I and II synthetases. Thus, it is
proper to invoke Ockham’s razor (34) in arguing that ancestral
synthetases were unlikely to have differed radically from the
HisRS and TrpRS Urzymes.
The results presented here complement our previous study
of the TrpRS Urzyme (15, 16) in several ways. This is the first
study of an Urzyme representing Class II aaRS. All HisRS
Urzymes were constructed without using protein design to
compensate for structural damage inflicted by deleting large
portions of the native enzyme. In retrospect, it will be interest-
ing to assess possible reasons for this relative independence
from mutational changes to the contemporary sequence. A
work inprogress isdevoted toamorecomprehensive testingof the
design parameters and their application to type II HisRS and
ProRS Urzymes. The immediate significance of this work, how-
ever, arises from our demonstration that the core catalytic activi-
ties of both Class I and Class II aminoacyl-tRNA synthetases can
be implemented in peptides as short as 120–130 amino acids,
containing their most highly conserved active site residues.
Relative Rate Enhancements Observed for Successive Frag-
mentation of Full-length HisRS Enzyme—Specific activities
illustrated in Fig. 5 are correlated, roughly, with the fitted kchem
(r  0.48) and kcat (r  0.72) parameters from the active site
titrations. The better correlation, as expected, is for kcat values.
The correlations are significantly better between values for the
first three constructs (r 0.97 and 0.99) than forHisRS4,whose
corrected activity is substantially higher than would be
expected from the active site titrations alone.
It is interesting to compare the relative rate enhancements
for a series of successively smaller E. coliHisRS active site frag-
ments (Fig. 7). The N-terminal catalytic domain studied previ-
ously (14) represents 76% of the full-length enzyme; its activity
is reduced by2000-fold.HisRS 1, 2, 3, and 4 represent, respec-
tively, 29%, 30%, 33%, and 35% of the full-length HisRS. Their
activities are reduced by 4–9  106-fold. An excellent linear
relationship exists between the fractional loss of mass and the
FIGURE 6. Michaelis-Menten kinetics for HisRS-3. Error bars denote the root mean square deviation for quadruplicate measurements at each concentration.
A, histidine dependence of 32PPi exchange. B, ATP-dependence of
32PPi exchange. Chisq is the goodness of fit, and R is the correlation coefficient between
observed and calculated values.
FIGURE 7. Relative rate enhancements for successive fragmentation of
the full-length E. coli HisRS. Relative rates from specific activity values for
the full-length enzyme and the full N-terminal catalytic domain (gray) were
taken from (14); those for HisRS-1– 4 are from this work.
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loss of ln(enzymatic activity) (R2  0.99, P(t)  0.0001) over
nearly seven orders of magnitude.
This observation reinforces the notion that historical
improvements in evolutionary fitness were associated with the
accumulation of modular blocks of new genetic information.
Furthermore, the insertion domains are clearly different pro-
tein folds in prokaryotic and eukaryotic HisRS. This implies
that the insertion domainwas probably themost recent domain
addition to the enzyme and suggests that it was acquired sub-
sequently to the HisA loop.
Large Fraction of Catalytically Active Molecules and Consis-
tent Dependence of Urzyme Activities on TEV Cleavage and
Presence of N- and C-terminal Extensions Afford Strong Evi-
dence for Authenticity of Observed Catalytic Activity—In our
previous study of the TrpRSUrzyme, we outlined six criteria by
which we could assess the authenticity of its catalytic activity.
The four most compelling of these criteria were as follows: the
high percentage (1%) of activemolecules contributing to the
observed activity in active site titrations, the cryptic nature of
the activity of the fusion protein, the fact that an active site
mutation altered the observed activity, and the unique value of
the Km value for tryptophan.
Similar criteria also establish the authenticity of the HisRS
Urzyme catalytic activities. Active site titration reveals signifi-
cant proportions of activemolecules (Fig. 4). Aswas true for the
MBP-TrpRS Urzyme fusion protein, the MBP fusion inacti-
vates the HisRS Urzymes by a factor of 50, relative to the
activity released upon TEV cleavage. Moreover, addition to the
minimal HisRS Urzyme of either the N-terminal extension to
Motif 1 orMotif3 enhances activity by reproducible amounts in
the fusion proteins and the TEV cleavage products (Fig. 5). The
consistent attribution of catalytic effects of Motif 3, the N-ter-
minal extension and their interaction in the regressionmodel in
Table 2 also argues strongly in favor of the authenticity of the
observed catalytic activity, as does the significant impact of the
HisRS-4 R113A active site mutation.
Results shown in Fig. 5 also establish important existence
proofs for the ability to manipulate modular structural details
related to catalytic activity. The approaches we used here may
prove useful in implicating short peptide segments, including
individual secondary structure elements, in modulating fitness
on a broader scale. Fuller characterization of the steady-state
kinetic parameters for HisRS1–4will be key to progressing fur-
ther along these lines.
HisRS-3 Urzyme Steady-state Kinetic Parameters Differ Sub-
stantially from Those of Native Full-length HisRS (Fig. 6)—The
Michaelis-Menten parameters are preliminary, andmust even-
tually be measured for all three constructs. Nevertheless, they
are significantly different from those either of the full-length
HisRS or theN-terminal catalytic domain (14). From the stand-
point of whether or not the observed activity can be attributed
reasonably to contaminating full-length enzyme, the important
parameters are the half-saturation values,Km, for ATP and his-
tidine. Contamination by wild-type HisRS would be half satu-
rated at [His] 30M and at [ATP] 890M.We observe half
saturation instead at [His] 209Mand at [ATP] 19M.The
Urzymes require seven times the histidine concentration and
yet require only 0.02 as much ATP as wild type HisRS. These
values far exceed the errors of the estimated Km parameters,
which are both 50%. We conclude from these comparisons
that the Urzyme kinetic parameters afford strong, orthogonal
evidence for the authenticity of HisRS 1–4 catalytic activities.
HisRS Urzyme Catalysis Likely Illustrates Catalytic Impor-
tance ofDistributedActive Site-binding Properties—TheR113A
mutation might have been expected to have a larger impact
than the observed 4-fold reduction. Themodest observed effect
suggests that the detailed electrostatic transition-state stabili-
zation by the arginine residue in the native enzyme is much
reduced in the Urzyme. In turn, this suggests that the observed
catalysis arises to a greater extent from the distributed substrate
binding properties of the active site. We noted a similar and
possibly related phenomenon with respect to the effect of the
D146A mutation in the TrpRS Urzyme.
Catalytic Activities of HisRS-1 and HisRS-2 Provide Comple-
mentary Support for Rodin-Ohno Hypothesis That Ancestral
Class I and II aaRSWere Encoded on Opposite Strands of Same
Gene—Rodin and Ohno (17) observed that codons for the con-
served, Motif 2 andMotif 1 catalytic signatures of Class II aaRS
were conspicuously homologous, respectively, to the reverse
complements of sequences coding for the corresponding
PxxxxHIGH and KMSKS catalytic signatures in the Class I
aaRS. This observation led them to propose that the two appar-
ently unrelated superfamilies descended from opposite strands
of the same ancestral gene. Our work on the TrpRS Urzyme
verified one essential prediction of the sense/antisense origin
hypothesis, that Class I catalytic activity did not require theCP1
insertion (15, 16, 28).
As Motif 3 is C-terminal to Motif 2, and as the PxxxxHIGH
signature is within 10 amino acids of the N terminus in
roughly half of the Class I synthetases, a comparable prediction
of the Rodin-Ohno hypothesis is that Motif 3 was not essential
for the catalytic activity of the progenitor Class II aaRS. We
have shown here that HisRS-1 and HisRS-2 catalyze histidine
activation at rates similar to those observed for the Class I
TrpRS Urzyme (15, 16), confirming a complementary experi-
mental prediction of the Rodin-Ohno hypothesis.
Significantly Different Rate Enhancements by Four HisRS
Urzymes Demonstrate That Amino Acid Activation Provides an
ExperimentalMetric for Recapitulating very Early Evolutionary
Events—The factorial design of the experiments reported here
illustrates that significant experimental differences in fitness
can be attributed to new blocks of genetic information. In par-
ticular, we have demonstrated improvements in catalytic activ-
ity associated with both Motif 3 and the N-terminal extension
to Motif 1. The four HisRS Urzymes range from 119 to 145
residues, representing two putative discontinuous evolutionary
stages in the generation of modern Class II aaRS. Table 1
emphasizes that the sensitivity of our 32PPi exchange assay suf-
fices to implicate both modules with different contributions to
histidine activation, which is certainly an appropriate metric of
fitness in the early evolution of translation.
Translation of the genetic code was a signal event in the ori-
gin of life, requiring not only the activation of amino acids,
considered here, but also the recognition and acyl transfer to
cognate tRNAs. Cognate tRNA is required for induced-fit
active site assembly in a subset of class I aaRS (35–37) and helps
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to coordinate the activities of the twomonomers in class II aaRS
dimers (38). It seems likely that ancestral synthetases developed
rudimentary functional integration of enzyme and tRNA.Dem-
onstration of experimental metrics for the HisRS and TrpRS
(16) Urzymes provide a realistic hope of unraveling their
evolution.
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